Skip to content

The effects of vitamin D on neuroimaging of autism spectrum disorder

The effects of vitamin D on neuroimaging of autism spectrum disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012846
Enrollment
Unknown
Registered
2017-09-30
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism spectrum disorder

Interventions

Group 1:vitamin D 800iu/d,p.o.
Group 2:vitamin D 150.000iu/d,im

Sponsors

The Firs Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. children with ASD; 2. Aged 2-15 years old; 3. The child guardian agrees to accept the clinical trial; 4. Vitamin D levels are below 30ng/ml.

Exclusion criteria

Exclusion criteria: 1. History of head trauma, neurological disease and serious somatic disease; 2. Children with uncontrollable seizures; 3. Medications that may affect MRS may have been used in the last two weeks; 4. The patient or the patient's guardian refused to accept telephone follow-up or revisits; 5. It has been clear that there are no sensitizers for sedatives; 6. There are metal implants or foreign bodies in the body; 7. The patient who installs the pacemaker.

Design outcomes

Primary

MeasureTime frame
Gesell Developmental test;Autism behavioral scale (ABC CARS M-CHAT-R etc.);level of vitamin D;MRS (GABA of hippocampus and frontal lobe);DTI of the whole brain;

Countries

China

Contacts

Public ContactJia Feiyong

The Firs Hospital of Jilin University

erkekangfujia@163.com+86 13943003914

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026